Abstract:Abstract SYNGAP1 is a major genetic risk factor for global developmental delay, autism spectrum disorder, and epileptic encephalopathy. De novo loss-of-function variants in this gene cause a neurodevelopmental disorder defined by cognitive impairment, social-communication disorder, and early-onset seizures. Cell biological studies in mouse and rat neurons have shown that Syngap1 regulates developing excitatory synapse structure and function, with loss-of-function variants driving formation of larger dendritic spines and stronger glutamatergic transmission. However, studies to date have been limited to mouse and rat neurons. Therefore, it remains unknown how SYNGAP1 loss-of-function impacts the development and function of human neurons. To address this, we employed CRISPR/Cas9 technology to ablate SYNGAP1 protein expression in neurons derived from a human induced pluripotent stem cell line (hiPSC). Reducing SynGAP protein expression in developing hiPSC-derived neurons enhanced dendritic morphogenesis, leading to larger neurons compared to those derived from isogenic controls. Consistent with larger dendritic fields, we also observed a greater number of morphologically defined excitatory synapses in cultures containing these neurons. Moreover, neurons with reduced SynGAP protein had stronger excitatory synapses and expressed synaptic activity earlier in development. Finally, distributed network spiking activity appeared earlier, was substantially elevated, and exhibited greater bursting behavior in SYNGAP1 null neurons. We conclude that SYNGAP1 regulates the postmitotic maturation of human neurons made from hiPSCs, which influences how activity develops within nascent neural networks. Alterations to this fundamental neurodevelopmental process may contribute to the etiology of SYNGAP1 -related disorders.

Anchoring high concentrations of SynGAP at postsynaptic densities via liquid-liquid phase separation.

Phase Transition in Postsynaptic Densities Underlies Formation of Synaptic Complexes and Synaptic Plasticity

O -GlcNAcylation modulates liquid–liquid phase separation of SynGAP/PSD-95

Gephyrin-mediated Formation of Inhibitory Postsynaptic Density Sheet Via Phase Separation.

Rapid dispersion of SynGAP from synaptic spines triggers AMPA receptor insertion and spine enlargement during LTP.

Synapsin condensation controls synaptic vesicle sequestering and dynamics

Phase Separation-Mediated TARP/MAGUK Complex Condensation and AMPA Receptor Synaptic Transmission

Reconstituted Postsynaptic Density As a Molecular Platform for Understanding Synapse Formation and Plasticity

Synaptic Targeting and Function of SAPAPs Mediated by Phosphorylation-Dependent Binding to PSD-95 MAGUKs

Mechanistic basis of MAGUK-organized complexes in synaptic development and signalling

A structural role for SynGAP

AIDA-1/ANKS1B binds to the SynGAP family RasGAPs with high affinity and specificity

Synapsin condensation is governed by sequence-encoded molecular grammars

Structural Basis of GABARAP-mediated GABAA Receptor Trafficking and Functions on GABAergic Synaptic Transmission

Direct interactions between PSD-95 and stargazin control synaptic AMPA receptor number

Phase separation-mediated actin bundling by the postsynaptic density condensates

Human SYNGAP1 Regulates the Development of Neuronal Activity by Controlling Dendritic and Synaptic Maturation

FAM81A is a postsynaptic protein that regulates the condensation of postsynaptic proteins via liquid–liquid phase separation

GSG1L Suppresses AMPA Receptor-Mediated Synaptic Transmission and Uniquely Modulates AMPA Receptor Kinetics in Hippocampal Neurons

Distinct SAP102 and PSD-95 Nano-organization Defines Multiple Types of Synaptic Scaffold Protein Domains at Single Synapses

Phase Separation As a Mechanism for Assembling Dynamic Postsynaptic Density Signalling Complexes